캐리어 스크리닝 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)
Carrier Screening Market (Type: Expanded Carrier Screening, Targeted Disease Carrier Screening; and Sample Type: Blood, Saliva, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
상품코드:1721229
리서치사:Transparency Market Research
발행일:2025년 03월
페이지 정보:영문 213 Pages
라이선스 & 가격 (부가세 별도)
한글목차
캐리어 스크리닝 시장 : 조사 범위
TMR의 조사 보고서 "세계 캐리어 스크리닝 시장"은 2025-2035년 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2025년을 기준 연도, 2035년을 예측 연도로 하여 2019년부터 2035년까지의 세계 캐리어 스크리닝 시장의 수익과 예측을 제공합니다. 또한, 2025년부터 2035년까지 세계 캐리어 스크리닝 시장의 CAGR%도 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 캐리어 스크리닝 시장을 이해하고자 했습니다.
시장 스냅샷
2024년 시장 규모
17억 달러
2035년 시장 규모
58억 달러
CAGR
11.8%
이 보고서에서는 세계 캐리어 스크리닝 시장의 경쟁 환경을 조사하고 있습니다. 세계 캐리어 스크리닝 시장에서 사업을 전개하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성별로 프로파일링되어 있습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등 세계 캐리어 스크리닝 시장의 주요 기업 속성이 본 보고서에서 소개됩니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 캐리어 스크리닝 시장 분석과 예측(2020-2035년)
제5장 주요 인사이트
주요 업계 이벤트
Porter's Five Forces 분석
공급망 분석
PESTEL 분석
기술적 진보
시장 미충족 수요
질병 역학
제6장 세계의 시장 분석과 예측 : 유형별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 유형별(2020-2035년)
확대 캐리어 스크리닝
대상 질환 캐리어 스크리닝
시장 매력 분석 : 유형별
제7장 세계의 시장 분석과 예측 : 샘플 유형별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 샘플 유형별(2020-2035년)
혈액
타액
기타
시장 매력 분석 : 샘플 유형별
제8장 세계의 시장 분석과 예측 : 기술별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 기술별(2020-2035년)
DNA 시퀀싱
중합효소 연쇄 반응
마이크로어레이
기타
시장 매력 분석 : 기술별
제9장 세계의 시장 분석과 예측 : 용도별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 용도별(2020-2035년)
낭포성 섬유증
테이삭스병
고셔병
겸상 적혈구증
기타
시장 매력 분석 : 용도별
제10장 세계의 시장 분석과 예측 : 최종사용자별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 최종사용자별(2020-2035년)
병원과 진료소
표준 실험실
기타
시장 매력 분석 : 최종사용자별
제11장 세계의 시장 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별(2020-2035년)
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 분석 : 지역별
제12장 북미의 시장 분석과 예측
제13장 유럽의 시장 분석과 예측
제14장 아시아태평양의 시장 분석과 예측
제15장 라틴아메리카의 시장 분석과 예측
제16장 중동 및 아프리카의 시장 분석과 예측
제17장 경쟁 구도
시장 기업 : 경쟁 매트릭스(기업 계층별·규모별)
시장 점유율 분석 : 기업별(2024년)
기업 개요
Myriad Genetics, Inc.
Cepheid
Illumina
Thermo Fisher Scientific, Inc.
F.Hoffmann-La Roche Ltd
LabCorp.
Otogenetics
MedGenome
GeneTech
Centogene N.V.
Fulgent Genetics
OPKO Health Inc.
Quest Diagnostics Incorporated
Natera Inc.
ksm
영문 목차
영문목차
Carrier Screening Market - Scope of Report
TMR's report on the global carrier screening market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global carrier screening market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global carrier screening market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the carrier screening market.
Market Snapshot
Market Value in 2024
US$ 1.7 Bn
Market Value in 2035
US$ 5.8 Bn
CAGR
11.8%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global carrier screening market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global carrier screening market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global carrier screening market.
The report delves into the competitive landscape of the global carrier screening market. Key players operating in the global carrier screening market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global carrier screening market profiled in this report.
Key Questions Answered in Global carrier screening market Report:
What is the sales/revenue generated by carrier screening across all regions during the forecast period?
What are the opportunities in the global carrier screening market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Carrier Screening Market - Research Objectives and Research Approach
The comprehensive report on the global carrier screening market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global carrier screening market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global carrier screening market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Carrier Screening Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Carrier Screening Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key Industry Events
5.2. PORTER's Five Forces Analysis
5.3. Supply Chain Analysis
5.4. PESTLE Analysis
5.5. Technological Advancements
5.6. Unmet Needs of the Market
5.7. Epidemiology of Diseases
6. Global Carrier Screening Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2035
6.3.1. Expanded Carrier Screening
6.3.2. Targeted Disease Carrier Screening
6.4. Market Attractiveness Analysis, by Type
7. Global Carrier Screening Market Analysis and Forecast, by Sample Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Sample Type, 2020-2035
7.3.1. Blood
7.3.2. Saliva
7.3.3. Others
7.4. Market Attractiveness Analysis, by Sample Type
8. Global Carrier Screening Market Analysis and Forecast, by Technique
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Technique, 2020-2035
8.3.1. DNA Sequencing
8.3.2. Polymerase Chain Reaction
8.3.3. Microarrays
8.3.4. Others
8.4. Market Attractiveness Analysis, by Technique
9. Global Carrier Screening Market Analysis and Forecast, by Application
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2020-2035
9.3.1. Cystic Fibrosis
9.3.2. Tay-Sachs
9.3.3. Gaucher Disease
9.3.4. Sickle Cell Disease
9.3.5. Others
9.4. Market Attractiveness Analysis, by Application
10. Global Carrier Screening Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020-2035
10.3.1. Hospitals & Clinics
10.3.2. Reference Laboratories
10.3.3. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Carrier Screening Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020-2035
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Carrier Screening Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020-2035
12.2.1. Expanded Carrier Screening
12.2.2. Targeted Disease Carrier Screening
12.3. Market Value Forecast, by Sample Type, 2020-2035
12.3.1. Blood
12.3.2. Saliva
12.3.3. Others
12.4. Market Value Forecast, by Technique, 2020-2035
12.4.1. DNA Sequencing
12.4.2. Polymerase Chain Reaction
12.4.3. Microarrays
12.4.4. Others
12.5. Market Value Forecast, by Application, 2020-2035
12.5.1. Cystic Fibrosis
12.5.2. Tay-Sachs
12.5.3. Gaucher Disease
12.5.4. Sickle Cell Disease
12.5.5. Others
12.6. Market Value Forecast, by End-user, 2020-2035
12.6.1. Hospitals & Clinics
12.6.2. Reference Laboratories
12.6.3. Others
12.7. Market Value Forecast, by Country, 2020-2035
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Sample Type
12.8.3. By Technique
12.8.4. By Application
12.8.5. By End-user
12.8.6. By Country
13. Europe Carrier Screening Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020-2035
13.2.1. Expanded Carrier Screening
13.2.2. Targeted Disease Carrier Screening
13.3. Market Value Forecast, by Sample Type, 2020-2035
13.3.1. Blood
13.3.2. Saliva
13.3.3. Others
13.4. Market Value Forecast, by Technique, 2020-2035
13.4.1. DNA Sequencing
13.4.2. Polymerase Chain Reaction
13.4.3. Microarrays
13.4.4. Others
13.5. Market Value Forecast, by Application, 2020-2035
13.5.1. Cystic Fibrosis
13.5.2. Tay-Sachs
13.5.3. Gaucher Disease
13.5.4. Sickle Cell Disease
13.5.5. Others
13.6. Market Value Forecast, by End-user, 2020-2035
13.6.1. Hospitals & Clinics
13.6.2. Reference Laboratories
13.6.3. Others
13.7. Market Value Forecast, by Country/Sub-region, 2020-2035
13.7.1. Germany
13.7.2. UK
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Sample Type
13.8.3. By Technique
13.8.4. By Application
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Carrier Screening Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020-2035
14.2.1. Expanded Carrier Screening
14.2.2. Targeted Disease Carrier Screening
14.3. Market Value Forecast, by Sample Type, 2020-2035
14.3.1. Blood
14.3.2. Saliva
14.3.3. Others
14.4. Market Value Forecast, by Technique, 2020-2035
14.4.1. DNA Sequencing
14.4.2. Polymerase Chain Reaction
14.4.3. Microarrays
14.4.4. Others
14.5. Market Value Forecast, by Application, 2020-2035
14.5.1. Cystic Fibrosis
14.5.2. Tay-Sachs
14.5.3. Gaucher Disease
14.5.4. Sickle Cell Disease
14.5.5. Others
14.6. Market Value Forecast, by End-user, 2020-2035
14.6.1. Hospitals & Clinics
14.6.2. Reference Laboratories
14.6.3. Others
14.7. Market Value Forecast, by Country/Sub-region, 2020-2035
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Sample Type
14.8.3. By Technique
14.8.4. By Application
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Carrier Screening Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2020-2035
15.2.1. Expanded Carrier Screening
15.2.2. Targeted Disease Carrier Screening
15.3. Market Value Forecast, by Sample Type, 2020-2035
15.3.1. Blood
15.3.2. Saliva
15.3.3. Others
15.4. Market Value Forecast, by Technique, 2020-2035
15.4.1. DNA Sequencing
15.4.2. Polymerase Chain Reaction
15.4.3. Microarrays
15.4.4. Others
15.5. Market Value Forecast, by Application, 2020-2035
15.5.1. Cystic Fibrosis
15.5.2. Tay-Sachs
15.5.3. Gaucher Disease
15.5.4. Sickle Cell Disease
15.5.5. Others
15.6. Market Value Forecast, by End-user, 2020-2035
15.6.1. Hospitals & Clinics
15.6.2. Reference Laboratories
15.6.3. Others
15.7. Market Value Forecast, by Country/Sub-region, 2020-2035
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Sample Type
15.8.3. By Technique
15.8.4. By Application
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Carrier Screening Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2020-2035
16.2.1. Expanded Carrier Screening
16.2.2. Targeted Disease Carrier Screening
16.3. Market Value Forecast, by Sample Type, 2020-2035
16.3.1. Blood
16.3.2. Saliva
16.3.3. Others
16.4. Market Value Forecast, by Technique, 2020-2035
16.4.1. DNA Sequencing
16.4.2. Polymerase Chain Reaction
16.4.3. Microarrays
16.4.4. Others
16.5. Market Value Forecast, by Application, 2020-2035
16.5.1. Cystic Fibrosis
16.5.2. Tay-Sachs
16.5.3. Gaucher Disease
16.5.4. Sickle Cell Disease
16.5.5. Others
16.6. Market Value Forecast, by End-user, 2020-2035
16.6.1. Hospitals & Clinics
16.6.2. Reference Laboratories
16.6.3. Others
16.7. Market Value Forecast, by Country/Sub-region, 2020-2035
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Sample Type
16.8.3. By Technique
16.8.4. By Application
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
